Abstract
In 1996, it was estimated that nearly 30600 people would be diagnosed with renal cell carcinoma with approximately 12000 deaths from this disease (Parker et al. 1996). Although this tumor most frequently occurs in patients in their fifth and sixth decades of life, it is not uncommon for it to occur in young, productive, and otherwise healthy adults or even children (Eckschlager and Kodet 1994). This disease clearly constitutes an important health problem in the United States. Currently, over 30% of patients diagnosed with renal cell carcinoma have metastatic disease at presentation. An additional 30%–50% of patients initially diagnosed with local disease will demonstrate locally advanced or even metastatic disease at the time of radical nephrectomy. These statistics, coupled with the lack of an effective adjuvant form of chemotherapy, radiotherapy, or immunotherapy (despite the initial enthusiasm) for renal cell carcinoma, emphasize that this is a surgical disease that needs to be detected and aggressively treated at an early curable stage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams HD, van Geetruyden HH (1956) Neurologic complications of aortic surgery. Ann Surg 144: 547–610
Allbright F (1941) Case records of the Massachusetts General Hospital - case 39061. N Engl J Med 225: 789–796
Aso Y, Homma Y (1992) A survey on incidental renal cell carcinoma in Japan. J Urol 147: 340–343
Beahrs OH, Myers MH (eds) (1983) American Joint Committee on Cancer: manual for staging cancer, 2nd edn. Lippincott, Philadelphia, 178
Belldegrun A, de Kernion JB (1988) Renal tumors. In: Walsh P, et al. (eds) Campbell’s urology. Saunders, Philadelphia, pp 2283–2326
Belldegrun A, Abi-Aad AS, Figlin RA, deKernion JB (1991) Renal cell carcinoma: basic and current approaches to therapy. Semin Oncol 18: 96–101
Belldegrun A, Pierce W, Kaboo R, et al. (1993) Interferonalpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as a therapy for metastatic renal cell carcinoma. J Urol 150: 1384–1390
Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG (1978)“Non-metastatic” hepatic dysfunction associated with renal cell carcinoma. J Urol 119: 468–471
Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG (1979)Renal carcinoma: computer analysis of 96 patients treated by nephrectomy. J Urol 122: 598–601
Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C (1995) Prognostic significance of incidental renal cell carcinoma. Eur Urol 27: 319–323
Chasan SA, Pothel RL, Huben RP (1989) Management and prognostic significance of hypercalcemia in renal cell carcinoma. Urology 33: 167–170
Cherukuri SV, Johenning PW, Ram MD (1977) Systemic effects of hypernephroma. Urology 10: 93–97
Chuang C-K, Lai M-K, Chang P-L, et al. (1992) Xanthogranulomatous pyelonephritis; experience in 36 cases. J Urol 147: 333–336
Chute R, Soutter L, Kerr WS (1949) The value of the thoracoabdominal incision in the removal of kidney tumors. N Engl J Med 241: 951–960
Cooper JF, Leadbetter WF, Chute R (1950) The thoracoab-dominal approach for retroperitoneal gland dissection: its application to testis tumors. Surg Gynecol Obstet 90: 486–496
Coulange C (1993) Enquete epidemiologique sur les tumeurs du rein. In: Abbou CC, Lobel B (eds) Synthese et Recommendations en Onco-Urologie. Monogr Prog Urol Paris, pp 200–202
Coupland GA, Reeve TS (1968) Paraplegia: a complication of excision of abdominal aortic aneurysm. Surgery 64: 879–881
Cranston WI, Luff RH, Owen D, Rawlins MD (1973) Studies on the pathogenesis of fever in renal carcinoma. Clin Sei Mol Med 45: 459–467
Creevy CD (1935) Confusing clinical manifestations of malignant renal neoplasms. Arch Intern Med 55: 895–916
Cronin RE, Kaehny WD, Miller PD, et al. (1976) Renal cell carcinoma: unusual systemic manifestations. Medicine 55: 291–311
Cummings KB, Robertson RP (1977) Prostaglandin: increased production by renal cell carcinoma. J Urol 118: 720–723
deKernion JB (1982) Treatment of advanced renal cell carcinoma–traditional methods and innovative approaches. J Urol 130: 2–7
Dinney CPN, Awad SA, Gajewski JB, et al. (1992) Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology 39: 122–129
Eckschlager T, Kodet R (1994) Renal cell carcinoma in children; a single institution’s experience. Med Pediatr Oncol 23: 36–39
Ferguson LRJ, Bergan JJ, Conn J Jr, Yao JST (1975) Spinal ischemia following abdominal aortic surgery. Ann Surg 181: 267–272
Figueroa AJ, Stein JP, Cunningham JA, Ginsberg DA, Skinner DG (1995) Xanthogranulomatous pyelonephritis in a pregnant woman: a case report and review of the literature. Urology 48: 294–297
Finney R (1973) The value of radiotherapy in the treatment of hypernephroma–a clinical trial. Br J Urol 45: 258–269
Flocks RH, Kadesky MC (1958) Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J Urol 79: 196–201
Gibbons RP, Montie JE, Correa RJ Jr, Mason JT (1976) Manifestations of renal cell carcinoma. Urology 8: 201–206
Giuliani L, Martorana G, Giberti C, Pescatore D, Magnani G (1983) Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 130: 664–668
Giuliani L, Giberti C, Martorana G, Rovida S (1990) Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143: 468–474
Glazer A A, Novick AC (1996) Long-term folio wup after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol 155: 448–450
Gold PJ, Fefer A, Thompson JA (1996) Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 14: 216–222
Goldberg RS, Pilcher DB, Yates JW (1980) The aggressive surgical management of hypercalcemia due to ectopic parathormone production. Cancer 45: 2652–2654
Golde DW, Schambelan M, Weintraub BD, et al. (1974) Gonadotropin-secreting renal carcinoma. Cancer 33:1048–1053
Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S, Morales P (1986) Renal cell carcinoma: survival and prognostic factors. Urology 27: 291–301
Gotoh A, Kitazawa S, Mizuno Y, et al. (1993) Common expression of parathyroid hormone-related protein and no correlation of calcium levels in renal cell carcinoma. Cancer 71: 2803–2806
Gross AJ, Wofff M, Fandrey J, et al. (1994) Prevalence of paraneoplastic erythropoietin production by renal cell carcinomas. Clin Invest 72: 123–130
Guinan PD, Ablin RJ, Dubin A, Nourkayhan S, Bush IM (1975) Carcinoembryonic antigen test in renal cell carcinoma. Urology 5: 185–187
Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51: 614–617
Hanash KA (1982) The nonmetastatic hepatic dysfunction syndrome associated with renal cell carcinoma (hypernephroma); Stauffer’s syndrome. Prog Clin Biol Res 100: 301–316
Hanash KA, Utz DC, Ludwig J, et al. (1971) Syndrome of reversible hepatic dysfunction associated with hyper-nephroma: an experimental study. Invest Urol 8: 399–404
Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145: 20–24
Hermanek P, Schrott KM (1990) Evaluation of the new tumor, nodes, and metastases classification of renal cell carcinoma. J Urol 144: 238–242
Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma? J Urol 146: 1224–1227
Hollifield JW, Page DL, Smith C, et al. (1975) Renin-secreting clear cell carcinoma of the kidney. Arch Intern Med 135: 859–864
Jobe BA, Bierman MH, Mezzacappa FJ, et al. (1993) Hyper-glycemia as a paraneoplastic endocrinopathy in renal cell carcinoma: a case report and review of the literature. Nebr Med J 78: 348–351
Juusela HM, Malmio K, Alfthan O, Oravisto KJ (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11: 277–281
Kantor AF (1977) Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J Urol 131:1053– 1055
Keily JM (1966) Hypernephroma–the internist’s tumor. Med Clin North Am 50: 1067–1083
Kessler O, Mukamel E, Hadar H, Gillon G, Konechezky M, Servadio C (1994) Effect of improved diagnosis of renal cell carcinoma on the course of the disease. J Surg Oncol 57: 201–204
Konnack JW, Grossman HB (1985) Renal cell carcimom as an incidental finding. J Urol 134: 1094–1096
Laski ME, Vugrin D (1987) Paraneoplastic syndromes in hypernephroma. Semin Nephrol 7: 123–130
Libertino JA, Zinman L, Watkins E Jr (1987) Long-term results of resection of renal cell cancer with extension into inferior vena cava. J Urol 137: 21–24
Lindop GBM, Fleming S (1984) Renin in renal cell carcinoma–an immune-cytochemical study using an antibody to pure human renin. J Clin Pathol 37: 27–31
Lytton B, Rosof B, Evans JS (1965) Parathyroid hormone-like activity in a renal carcinoma producing hypercalcemia. J Urol 93: 127–131
Maldazys JD, deKernion JB (1986) Prognostic factors in renal carcinoma. J Urol 136: 376–379
Malek RS, Elder JS (1978) Hypernephroma in the solitary kidney: experience with 20 cases and review of the literature. J Urol 116: 553–556
Mantyla M, Nordman E, Minkkinen J (1977) Postopertive radiotherapy of renal adenocarcinoma. Ann Clin Res 9: 252–256
Marshall FF, Powell KC (1982) Lymphadenectomy for renal cell carcinoma: anatomical and therapeutic consider¬ations. J Urol 128: 677–681
McDougal WS, Garnick MB (1995) Clinical signs and symptoms of renal cell carcinoma. In: Vogelzang NJ, Shipley WU, Scardino PT, et al. (eds) Comprehensive textbook of genitourinary oncology. Williams 8c Wilkins, Baltimore, pp 154–159
McNicholos DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long–term survival and late recurrence. J Urol 126: 17–23
Medeiros LJ, Gelb AB, Weiss LM (1987) Low-grade renal cell carcinoma: a clinicopathologic study of 53 cases. Am J Surg Pathol 11: 633–642
Medeiros LJ, Gelb AB, Weiss LM (1988) Renal cell carcinoma: prognostic significance of morphologic parameters in 121 cases. Cancer 61: 1639–1651
Middleton AW Jr (1980) Indications for and results of nephrectomy for metastatic renal cell carcinoma. Urol Clin North Am 7: 711–717
Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Valamis V, Krown SE (1993) Interferon alpha-2a in advanced renal cell carcinoma. Treatment results and survival in 159 patients with long-term follow-up. J Clin Oncol 11: 1368–1375
Mrstik S, Salamon J, Weber R, Stogermayer F (1992) Microscopic venous infiltration as predictor of relapse in renal cell carcinonoma. J Urol 148: 271–274
Muggia FM (1990) Overview of cancer-related hypercalcemia: epidemiology and etiology. Semin Oncol 17: 3–9
Nakano E, Iwasaki A, Seguchi T, et al. (1992) Incidentally diagnosed renal cell carcinoma. Eur Urol 21: 294–298
Nielsen HO (1973) Arterial hypertension due to a renin-producing renal carcinoma. Scand J Urol Nephrol 9:293– 296
Nurmi MJ (1984) Prognostic factors in renal carcinoma: an evaluation of operative findings. Br J Urol 56: 270–275
O’Dea MJ, Zincke H, Utz DC, Bernatz PE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120: 540–542
O’Grady AS, Morse LJ, Lee JB (1965) Parathyroid hormone– secreting renal carcinoma associated with hypercalcemia and metabolic alkalosis. Ann Intern Med 63: 858–868
Palgon N, Greestein F, Novetsky AD, Lichter SM, Rosen Y (1986) Hyperglycemia associated with renal cell carci–noma. Urology 28: 516–517
Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46: 5–27
Peeling WB, Mantell BS, Shepheard BGF (1969) Post-operative irradiation in the treatment of renal cell carcinoma. Br J Urol 41: 23–31
Peters PC, Brown GL (1980) The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am 7: 705–709
Pizzocaro G, Piva L (1990) Pros and cons of retroperitoneal lymphadenectomy in operable renal cell carcinoma. Eur Urol 18: 22–23
Rafia S (1970) Renal cell carcinoma–natural history and results of treatment. Cancer 25: 26–40
Ramos CV, Taylor HB (1972) Hepatic dysfunction associated with renal carcinoma. Cancer 29: 1287–1292
Riches E (1966) The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol 95: 313–317
Riggs BL, Sprague RG (1961) Association of Cushing’s syndrome and neoplastic disease. Arch Intern Med 108:841– 849
Ritch PS (1990) Treatment of cancer-related hypercalcemia. Semin Oncol 17: 26–33
Robson CJ (1963) Radical nephrectomy for renal cell carcinoma. J Urol 89: 37–42
Robson CJ (1982) The natural history of renal cell carcinoma. Prog Clin Biol Res 100: 447–452
Robson CJ, Churchill BM, Andersen W (1968) The results of radical nephrectomy for renal cell carcinoma. Trans Am Assoc Genitourin Surg 60: 122–129
Robson CJ, Churchill BM, Andersen W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297–301
Rosenblum SL (1987) Paraneoplastic syndromes associated with renal cell carcinoma. JSC Med Assoc 83: 375–378
Rost A, Brosig W (1977) Preoperative irradiation of renal cell carcinoma. Urology 10: 414–417
Sago AL, Ball TP, Novicki DE (1979) Complications of retro-peritoneal lymphadenectomy. Urology 13: 241–243
Samaan NA (1979) Paraneoplastic syndromes associated with renal cell carcinoma. In: Johnson DE, Samuels ML (eds) Clinical conference on cancer–cancer of the genitourinary tract. Raven Press, New York, pp 73–78
Selli C, Hinshaw WM, Woodard BH, Paulson DF (1983) Stratification of risk factors in renal cell carcinoma. Cancer 52: 899–903
Siminovitch JMP, Montie JE, Straffon RA (1983) Prognostic indicators in renal adenocarcinoma. J Urol 130: 20–23
Skinner DG, Colvin RB, Vermillion CD, et al. (1971) Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer 28: 1165–1177
Skinner DG, Pfister RF, Colvin R (1972a) Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol 107: 711–716
Skinner DG, Vermillion CD, Colvin RB (1972b) The surgical management of renal cell carcinoma. J Urol 107: 705–710
Skinner DG, Pritchett TR, Lieskowsky G, Boyd SD, Stiles QR (1989) Vena caval involvement by renal cell carcinoma. Ann Surg 210: 387–394
Stauffer MH (1961) Nephrogenic hepatosplenomegaly (abstract). Gastroenterology 40: 694
Stein JP, Esrig D, Eastham J, et al. (1998) The surgical management for renal cell carcinoma: long-term results in a large group of patients. J Urol (accepted for publication)
Strewler GJ, Stern PH, Jacobs JW, et al. (1987) Parathyroid hormone-like protein from human renal carcinoma cells. J Clin Invest 80: 1803–1807
Studer UE, Scherz S, Scheidegger J, et al. (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144: 243–245
Sufrin G, Mirand EA, Moore RH, et al. (1977) Hormones in renal cancer. J Urol 117: 433–438
Suva LJ, Winslow REH, Wettenhall RG, et al. (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–896
Swanson DA, Borges PM (1983) Complications of trans-abdominal radical nephrectomy for renal cell carcinoma. J Urol 129: 704–707
Sweet RH (1947) Carcinoma of the esophagus and the cardiac end of the stomach. JAMA 135: 485–490
Swierzewski DJ, Swierzewski MJ, Libertino JA (1994) Radical nephrectomy in patients wth renal cell carcinoma with venous, vena caval and atrial extension. Am J Surg 168: 205–209
Tanguay S, Swansom DA, Putnam JB Jr (1996) Renal cell carcinoma metastatic to the lung: potential benefit in the combination of biological therapy and surgery. J Urol 156: 1586–1589
Thompson IM, Peek M (1988) Improvement in survival of patients with renal cell carcinoma–the role of the serendipitously detected tumor. J Urol 140: 487–490
Thrasher JB, Paulson DF (1993) Prognostic factors in renal cancer. Urol Clin North Am 20: 247–262
Tsukamoto T, Kumamoto Y, Miyao N, Yamazaki K, Takahashi A, Satoh M (1990) Regional lymph node metastasis in renal cell carcinoma: incidence, distribution and its relation to other pathological fingings. Eur Urol 18: 88–93
Tsukamoto T, Kumamoto Y, Yamazaki K, et al. (1991) Clinical analysis of incidentally found renal cell carcinomas. Eur Urol 19: 109–113
Tsukamoto T, Kumamoto Y, Miyao N, Masumori N, Takahashi A, Yanase M (1992) Interleukin-6 in renal cell carcinoma. J Urol 148: 1778–1782
Turkington RW (1971) Ectopic production of prolactin. N Engl J Med 285: 1455–1461
Umeda T, Niijima T (1986) Phase II study of alpha interferon on renal cell carcinoma: summary of three collaborative trials. Cancer 58: 1231–1235
Utz DC, Warren MM, Gregg J A, Ludwig J, Kelalis PP (1970) Reversible hepatic dysfunction associated with hyper-nephroma. Mayo Clin Proc 45: 161–169
Vallancien G, Torres LO, Gurfinkel E, Veillon B, Brisset JM (1990) Incidental detection of renal tumors by abdominal ultrasonography. Eur Urol 18: 94–96
van der Werf-Messing B (1973) Carcinoma of the kidney. Cancer 32: 1056–1061
Walsh PN, Kissane JM (1968) Nonmetastatic hypernephroma with reversible hepatic dysfunction. Arch Intern Med 122: 214–222
Walther MM, Alexander RB, Weiss GH, et al. (1993) Cytoreductive surgey prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology 42: 250–258
Wood DP Jr (1991) Role of lymphadenectomy in renal cell carcinoma. Urol Oncol 18: 421
Yagoda A, Abi-Rached B, Petrylak D (1995) Chemotherapy for advanced renal cell carcinoma: 1983–1993. Semin Oncol 22: 42–60
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stein, J.P., Skinner, D.G. (1999). Radical Nephrectomy. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59839-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-59839-5_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64144-2
Online ISBN: 978-3-642-59839-5
eBook Packages: Springer Book Archive